Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
601811 Xinhua Winshare publishing & Media
- 15.63
- +0.41+2.69%
Not Open Apr 1 15:00 CST
19.28BMarket Cap12.48P/E (TTM)
15.69High15.09Low117.37KlotVolume15.21Open15.22Pre Close181.56MTurnover1.48%Turnover Ratio12.48P/E (Static)1.23BShares17.0652wk High1.32P/B12.38BFloat Cap12.5952wk Low16.74Limit Up791.90MShs Float32.64Historical High13.70Limit Down3.94%Amplitude5.75Historical Low0.77Dividend TTM15.47Avg Price52.87KlotAsk4.93%Div YieldTTM100Lot Size60.01KlotBid
Xinhua Winshare publishing & Media Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 0.83%12.94B | 0.91%8.25B | 2.52%5.65B | -3.75%2.55B | 13.84%12.83B | 12.81%8.18B | 10.25%5.51B | 10.79%2.65B | 1.39%11.27B | -3.86%7.25B |
| Refunds of taxes and levies | 145.09%97.51M | -17.53%32.54M | -99.08%345.66K | ---- | -62.35%39.78M | -62.28%39.45M | 1.17%37.54M | ---- | 280.80%105.67M | 273.02%104.59M |
| Cash received relating to other operating activities | 25.33%393.9M | -36.38%167.93M | 3.02%124.55M | -6.23%102.02M | 13.69%314.28M | 24.89%263.96M | 12.79%120.9M | 22.98%108.79M | 30.24%276.43M | 36.13%211.35M |
| Cash inflows from operating activities | 1.85%13.43B | -0.34%8.45B | 1.86%5.78B | -3.85%2.66B | 13.15%13.19B | 12.10%8.48B | 10.24%5.67B | 11.22%2.76B | 2.61%11.65B | -2.05%7.56B |
| Goods services cash paid | 4.66%8.13B | 1.04%5.25B | 3.39%3.57B | -12.12%1.38B | 10.99%7.77B | 8.56%5.19B | 5.20%3.46B | -5.82%1.57B | 4.30%7B | 6.59%4.78B |
| Staff behalf paid | 7.18%1.84B | 9.01%1.53B | 10.08%1.21B | 16.45%873.7M | 16.18%1.72B | 18.34%1.4B | 18.44%1.1B | 21.60%750.28M | 10.90%1.48B | 12.06%1.18B |
| All taxes paid | 152.17%386.52M | 145.91%264.18M | 126.94%152.49M | 88.38%62.23M | 3.21%153.27M | 20.38%107.43M | -12.27%67.2M | -36.69%33.04M | -6.54%148.51M | -19.16%89.24M |
| Cash paid relating to other operating activities | 8.91%1.3B | 2.23%641.16M | -1.10%463.71M | -10.53%214.6M | 18.95%1.19B | -3.33%627.19M | 7.60%468.86M | 15.53%239.85M | -9.40%1B | -18.61%648.79M |
| Cash outflows from operating activities | 7.61%11.66B | 4.79%7.68B | 6.05%5.4B | -2.41%2.53B | 12.50%10.83B | 9.29%7.33B | 7.73%5.09B | 1.95%2.59B | 3.43%9.63B | 3.93%6.71B |
| Net cash flows from operating activities | -24.67%1.77B | -32.99%771.03M | -34.75%379.84M | -25.13%130.62M | 16.23%2.35B | 34.08%1.15B | 38.37%582.15M | 419.07%174.46M | -1.12%2.02B | -32.44%858.14M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -84.21%28.45M | -97.90%3.43M | -99.41%913.99K | -99.10%566.23K | -42.28%180.13M | -44.05%162.97M | -38.47%154.68M | 58.55%63.23M | -10.88%312.09M | -5.17%291.26M |
| Cash received from returns on investments | 102.56%195.52M | 96.96%177.49M | 2,325.25%36.05M | ---- | -4.37%96.52M | -17.13%90.12M | -98.49%1.49M | -40.61%1.49M | 37.99%100.94M | 43.18%108.74M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -60.71%2.39M | 161.17%2.09M | 262.91%1.98M | -48.47%198.43K | -85.35%6.1M | -97.95%799.14K | -98.59%546.95K | -98.50%385.09K | 953.93%41.6M | 1,491.88%39.07M |
| Cash received relating to other investing activities | 239.60%890M | 410.00%510M | 495.34%300M | ---- | -60.17%262.08M | -82.00%100M | -87.57%50.39M | --50M | --658.06M | --555.5M |
| Cash inflows from investing activities | 104.90%1.12B | 95.83%693.01M | 63.66%338.95M | -99.34%764.66K | -51.04%544.82M | -64.42%353.89M | -73.93%207.11M | 69.17%115.1M | 160.40%1.11B | 157.97%994.58M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -16.23%151.2M | -8.98%93.57M | 10.71%51.54M | -45.66%14.37M | -16.71%180.49M | -21.90%102.8M | -59.87%46.55M | -58.71%26.44M | -20.84%216.71M | -24.99%131.64M |
| Cash paid to acquire investments | -5.21%211.76M | -5.25%211.66M | 37.92%211.56M | -81.39%5.3M | 16.48%223.41M | 16.48%223.39M | -20.01%153.39M | -85.15%28.49M | -69.66%191.8M | -69.46%191.78M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --71.73M | ---- |
| Cash paid relating to other investing activities | 161.91%1.58B | 304.00%1.01B | 710.00%810M | ---- | 50.47%601.87M | -16.67%250M | -66.67%100M | ---- | -50.00%400M | -57.14%300M |
| Cash outflows from investing activities | 92.82%1.94B | 128.26%1.32B | 257.77%1.07B | -64.19%19.67M | 14.26%1.01B | -7.58%576.19M | -50.65%299.94M | -82.04%54.93M | -48.40%880.24M | -58.53%623.42M |
| Net cash flows from investing activities | -78.53%-822.95M | -179.90%-622.23M | -690.83%-734.14M | -131.42%-18.91M | -298.31%-460.95M | -159.89%-222.3M | -149.73%-92.83M | 125.31%60.18M | 118.18%232.44M | 133.20%371.16M |
| Financing cash flow | ||||||||||
| Cash from borrowing | 0.00%10M | ---- | ---- | ---- | -44.44%10M | --10M | ---- | ---- | --18M | ---- |
| Cash inflows from financing activities | 0.00%10M | ---- | ---- | ---- | -44.44%10M | --10M | ---- | ---- | --18M | ---- |
| Borrowing repayment | -44.44%10M | --10M | ---- | ---- | --18M | ---- | ---- | ---- | ---- | ---- |
| Dividend interest payment | 125.96%950.88M | 70.46%715.9M | 99.96%539.03M | 150,139.37%222.09M | 6.42%420.82M | 6.37%419.99M | 6.37%269.56M | --147.83K | 3.24%395.41M | 3.23%394.83M |
| -Including:Cash payments for dividends or profit to minority shareholders | -1.72%559.57K | ---- | ---- | ---- | 0.34%569.36K | ---- | ---- | ---- | 9.80%567.44K | ---- |
| Cash payments relating to other financing activities | -22.17%114.41M | 5.66%102.67M | 0.09%40.14M | 38.63%21.94M | 27.72%147M | -3.49%97.17M | -6.25%40.11M | -24.52%15.82M | -10.62%115.1M | 37.46%100.68M |
| Cash outflows from financing activities | 83.55%1.08B | 60.21%828.56M | 87.03%579.17M | 1,427.88%244.03M | 14.75%585.82M | 4.37%517.16M | 4.55%309.67M | -23.82%15.97M | -0.25%510.51M | 8.73%495.51M |
| Net cash flows from financing activities | -85.00%-1.07B | -63.37%-828.56M | -87.03%-579.17M | -1,427.88%-244.03M | -16.92%-575.82M | -2.35%-507.16M | -4.55%-309.67M | 23.82%-15.97M | 3.77%-492.51M | -8.73%-495.51M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | -108.79%-115.76M | -261.41%-679.76M | -619.61%-933.48M | -160.51%-132.31M | -25.40%1.32B | -42.61%421.14M | -42.27%179.65M | 169.76%218.66M | 586.69%1.76B | 341.89%733.79M |
| Add:Begin period cash and cash equivalents | 16.96%9.08B | 16.96%9.08B | 16.96%9.08B | 16.95%9.08B | 29.42%7.76B | 29.42%7.76B | 29.42%7.76B | 29.42%7.76B | 4.48%6B | 4.48%6B |
| End period cash equivalent | -1.28%8.96B | 2.63%8.4B | 2.56%8.14B | 12.09%8.95B | 16.96%9.08B | 21.57%8.18B | 25.88%7.94B | 40.40%7.98B | 29.42%7.76B | 23.80%6.73B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.